Disparities in mental health diagnosis, treatment, and outcomes significantly affect racial, ethnic, and LGBTQIA+ groups. These populations face barriers such as lower diagnosis rates, inadequate treatment, and poorer outcomes compared to their White, non-LGBTQIA+ counterparts. For instance, Latine patients use …
Disparities in the diagnosis, treatment, and outcomes of cardiovascular disorders, including hypertension, disproportionately affect underserved racial and ethnic populations as well as the LGBTQIA+ community. These groups face significant barriers, such as lower rates of hypertension control, increased cardiovascular mortality, …
Despite the associated high probability of fetal risks in pregnant patients, mycophenolate remains one of the most commonly used immunosuppressants for patients receiving a solid organ transplant (SOT). To help combat the risks associated with mycophenolate treatment, the ongoing FDA …
Health inequities in the diagnosis, treatment, and outcomes of gastrointestinal disorders significantly impact racial, ethnic, and immigrant populations. Patients born outside the U.S. are less likely to be diagnosed with inflammatory bowel disease (IBD) before age 16 and often face …
In this CME Outfitters live symposium, expert faculty will address biomarker testing in community oncology settings and its impact on treatment selection and patient outcomes, particularly in underserved patient populations. Education is needed on available biomarker testing strategies in prostate, …
The 2022 Clinical Practice Guideline for Prescribing Opioids for Pain, developed by the Centers for Disease Control and Prevention (CDC), was introduced as an update to the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. This update aimed to …
Ulcerative colitis (UC) affects around three million people in the United States. Delays in treatment coverage approval, costs of managing the disease, and uncertainties around new treatment options significantly impact how well patients react to treatment, and short- and long-term …
Crohn’s disease (CD) can cause progressive bowel damage, impaired quality of life, and permanent disability. Severity and presentation can vary widely from person to person, necessitating an individualized treatment approach. The use of more readily available imaging modalities such as …
Crohn’s disease (CD) can cause progressive bowel damage, impaired quality of life, and permanent disability. Severity and presentation can vary widely from person to person, necessitating an individualized treatment approach. The use of more readily available imaging modalities such as …